Sesena-Rubfiaro A, Prajapati N, Paolino L, Lou L, Cotayo D, Pandey P
ACS Biomater Sci Eng. 2023; 9(3):1644-1655.
PMID: 36765460
PMC: 10542861.
DOI: 10.1021/acsbiomaterials.2c01370.
Minor A, Coulombe K
Stem Cells Transl Med. 2022; 11(1):97-106.
PMID: 35641165
PMC: 8895492.
DOI: 10.1093/stcltm/szab002.
Boheler K, Poon E
Pflugers Arch. 2021; 473(7):1023-1039.
PMID: 33928456
DOI: 10.1007/s00424-021-02549-8.
Liu T, Zhang S, Huang C, Ma S, Bai R, Li Y
J Cell Mol Med. 2021; 25(7):3469-3483.
PMID: 33689230
PMC: 8034460.
DOI: 10.1111/jcmm.16429.
Hasan A, Mohammadi N, Nawaz A, Kodagoda T, Diakonov I, Harding S
Cells. 2020; 9(10).
PMID: 33053822
PMC: 7601768.
DOI: 10.3390/cells9102275.
Hypertrophy of human embryonic stem cell-derived cardiomyocytes supported by positive feedback between Ca and diacylglycerol signals.
Deisl C, Fine M, Moe O, Hilgemann D
Pflugers Arch. 2019; 471(8):1143-1157.
PMID: 31250095
PMC: 6614165.
DOI: 10.1007/s00424-019-02293-0.
Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues.
Chow M, Sadrian S, Keung W, Geng L, Ren L, Kong C
Sci Rep. 2019; 9(1):7502.
PMID: 31097748
PMC: 6522495.
DOI: 10.1038/s41598-019-42953-w.
Hemodynamic Stimulation Using the Biomimetic Cardiac Tissue Model (BCTM) Enhances Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Rogers A, Kannappan R, Abukhalifeh H, Ghazal M, Miller J, El-Baz A
Cells Tissues Organs. 2019; 206(1-2):82-94.
PMID: 30840966
PMC: 7765732.
DOI: 10.1159/000496934.
Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
Tan S, Ye L
J Cardiovasc Transl Res. 2018; 11(5):375-392.
PMID: 29557052
DOI: 10.1007/s12265-018-9801-5.
Cardiac Progenitors Induced from Human Induced Pluripotent Stem Cells with Cardiogenic Small Molecule Effectively Regenerate Infarcted Hearts and Attenuate Fibrosis.
Xuan W, Wang Y, Tang Y, Ali A, Hu H, Maienschein-Cline M
Shock. 2018; 50(6):627-639.
PMID: 29485473
PMC: 6109623.
DOI: 10.1097/SHK.0000000000001133.
Regulation of Cardiomyocyte T-Tubular Structure: Opportunities for Therapy.
Manfra O, Frisk M, Louch W
Curr Heart Fail Rep. 2017; 14(3):167-178.
PMID: 28447290
PMC: 5423965.
DOI: 10.1007/s11897-017-0329-9.
Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.
Smith A, Macadangdang J, Leung W, Laflamme M, Kim D
Biotechnol Adv. 2016; 35(1):77-94.
PMID: 28007615
PMC: 5237393.
DOI: 10.1016/j.biotechadv.2016.12.002.
Non-cell autonomous cues for enhanced functionality of human embryonic stem cell-derived cardiomyocytes via maturation of sarcolemmal and mitochondrial K channels.
Keung W, Ren L, Li S, Wong A, Chopra A, Kong C
Sci Rep. 2016; 6:34154.
PMID: 27677332
PMC: 5039730.
DOI: 10.1038/srep34154.
High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.
Del Alamo J, Lemons D, Serrano R, Savchenko A, Cerignoli F, Bodmer R
Biochim Biophys Acta. 2016; 1863(7 Pt B):1717-27.
PMID: 26952934
PMC: 4885786.
DOI: 10.1016/j.bbamcr.2016.03.003.
Strategies and Challenges to Myocardial Replacement Therapy.
Feric N, Radisic M
Stem Cells Transl Med. 2016; 5(4):410-6.
PMID: 26933042
PMC: 4798743.
DOI: 10.5966/sctm.2015-0288.
Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
Bedada F, Wheelwright M, Metzger J
Biochim Biophys Acta. 2015; 1863(7 Pt B):1829-38.
PMID: 26578113
PMC: 4864165.
DOI: 10.1016/j.bbamcr.2015.11.005.
Morphometric Analysis of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes: Determining the Maturation State of a Population by Quantifying Parameters in Individual Cells.
Chan H, Keung W, Li R, Miller A, Webb S
Stem Cells Int. 2015; 2015:586908.
PMID: 26351464
PMC: 4553338.
DOI: 10.1155/2015/586908.
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.
Feric N, Radisic M
Adv Drug Deliv Rev. 2015; 96:110-34.
PMID: 25956564
PMC: 4635107.
DOI: 10.1016/j.addr.2015.04.019.
Calcium signalling in developing cardiomyocytes: implications for model systems and disease.
Louch W, Koivumaki J, Tavi P
J Physiol. 2015; 593(5):1047-63.
PMID: 25641733
PMC: 4358669.
DOI: 10.1113/jphysiol.2014.274712.
Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.
Keung W, Boheler K, Li R
Stem Cell Res Ther. 2014; 5(1):17.
PMID: 24467782
PMC: 4055054.
DOI: 10.1186/scrt406.